- Home
- Taking on heart disease
Taking on heart disease
At Johnson & Johnson, we have an unrelenting vision to ease the tremendous global burden of cardiovascular disease. From anticoagulation, to advanced mapping and catheter ablation to treat atrial fibrillation, to cutting-edge technology that enables heart recovery through temporarily assisting the pumping function of the heart, to next generation investigational antithrombotics with the potential to help address unmet needs in acute coronary syndrome and stroke, our medical technologies and therapeutics are helping treat some of the most prevalent heart conditions, driving better outcomes and lasting impact for patients.
Innovating in Health&Care
5 things we now know about atrial fibrillation
More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. Learn the facts behind this heart condition, plus one patient’s diagnosis story.
Do you know what heart failure is? (Hint: It’s probably not what you think)
Learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health
Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.
What’s the difference between a heart attack and cardiac arrest?
Both are life-threatening heart-health emergencies, but they are two distinct conditions with different causes and treatment. Here’s what a cardiologist wants you to know.
What is cardiac ablation?
Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
More from Johnson & Johnson
Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list
The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.
Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.